Skip to main content
Xinjiang Xuefeng Sci-Tech (Group) Co.,Ltd logo

Xinjiang Xuefeng Sci-Tech (Group) Co.,Ltd — Investor Relations & Filings

Ticker · 603227 ISIN · CNE100002243 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,503 across all filing types
Latest filing 2022-05-31 AGM Information
Country CN China
Listing Shanghai Stock Exchange 603227

About Xinjiang Xuefeng Sci-Tech (Group) Co.,Ltd

https://www.xjxfkj.com

Xinjiang Xuefeng Sci-Tech (Group) Co.,Ltd. focuses on the research, development, production, and distribution of civil explosives and chemical products. The company's primary product line includes industrial explosives, digital electronic detonators, and industrial primers. It also operates a large-scale chemical manufacturing division producing liquid ammonia, nitric acid, ammonium nitrate, and compound fertilizers. In addition to product manufacturing, the group provides integrated blasting services, engineering design, and technical consulting for mining, infrastructure, and water conservancy projects. By maintaining a vertically integrated business model, the company delivers comprehensive solutions ranging from raw material supply to specialized engineering execution and logistics.

Recent filings

Filing Released Lang Actions
新疆雪峰科技（集团）股份有限公司2022年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the 2022 second extraordinary shareholders meeting of Xinjiang Xuefeng Technology (Group) Co., Ltd. It contains detailed proposals (议案) related to the issuance of shares and payment of cash to purchase assets and raise supporting funds, including asset valuation, transaction parties, pricing, payment methods, share issuance plans, lock-up periods, and compliance with regulatory requirements. The content is focused on a major asset restructuring transaction involving issuance of shares and cash payment to acquire 100% equity of another company, with detailed legal and regulatory compliance explanations. This is typical of documentation prepared for a shareholders meeting to approve a major transaction and related financing. The document is not a financial report, audit report, earnings release, or call transcript. It is not a simple announcement or a proxy solicitation but rather the meeting materials (agenda and detailed proposals) for an extraordinary general meeting (EGM) or shareholders meeting. Given the nature of the content as meeting materials for shareholder approval of a major transaction, the appropriate classification is AGM Information (AGM-R).
2022-05-31 Chinese
董事会关于本次重组相关主体不存在依据《上市公司监管指引第7号——上市公司重大资产重组相关股票异常交易监管》第十三条不得参与任何上市公司重大资产重组情形的说明
Regulatory Filings Classification · 95% confidence The document is a statement from the board of directors of Xinjiang Xuefeng Technology (Group) Co., Ltd. regarding the compliance of the parties involved in a major asset restructuring with regulatory guidelines, specifically referencing the 'Guideline No. 7 on Abnormal Stock Trading Related to Major Asset Restructuring of Listed Companies.' It clarifies that none of the involved parties are under investigation or have been penalized for insider trading related to this restructuring. The document is an announcement related to a major asset restructuring but does not contain financial statements or detailed financial data. It is not a full report but a regulatory compliance statement related to a restructuring transaction. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-05-25 Chinese
新疆雪峰科技（集团）股份有限公司第三届董事会第三十八次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement of resolutions passed by the board of directors of Xinjiang Xuefeng Technology (Group) Co., Ltd. regarding a major transaction involving issuance of shares and payment of cash to purchase assets and raise supporting funds. It includes detailed descriptions of the transaction, asset valuation, pricing, payment methods, share issuance plans, lock-up periods, legal compliance, and related party transactions. The document references compliance with Chinese securities laws and regulations, the China Securities Regulatory Commission (CSRC), and the Shanghai Stock Exchange (SSE). It is a formal board meeting resolution announcement related to a significant capital and asset restructuring transaction, including issuance of shares and financing. The document is not a full annual or interim report, audit report, or earnings release. It is not a proxy statement or voting results announcement, but a board resolution announcement about a capital/financing transaction. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed substantive content about the financing transaction, not just an announcement of a report publication or a regulatory filing. Confidence is high due to the detailed transaction and financing content and the nature of the document as a board meeting resolution on capital raising and asset purchase.
2022-05-25 Chinese
董事会关于本次交易不构成《上市公司重大资产重组管理办法》第十三条规定的重组上市情形的说明
Regulatory Filings Classification · 95% confidence The document is a statement from the board of directors of Xinjiang Xuefeng Technology (Group) Co., Ltd. explaining that a proposed transaction does not constitute a major asset restructuring under the relevant regulatory rules (specifically Article 13 of the Measures for the Administration of Major Asset Restructurings of Listed Companies). It discusses the nature of the transaction, regulatory criteria, and concludes that the transaction does not trigger the regulatory requirements for a major asset restructuring. The document is a formal announcement or explanation by the board rather than a full report or financial statement. It is not an annual report, audit report, earnings release, or any other detailed financial report. It is also not a proxy statement or voting result. Given the content and length (1328 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-05-25 Chinese
董事会关于本次重大资产重组履行法定程序完备性、合规性及提交法律文件的有效性的说明
Board/Management Information Classification · 95% confidence The document is a detailed explanation from the board of directors of Xinjiang Xuefeng Technology (Group) Co., Ltd. regarding the completeness, compliance, and validity of legal documents submitted for a major asset restructuring involving issuance of shares and cash payment. It references various regulatory requirements, legal procedures, and approvals related to a significant asset acquisition and capital raising transaction. The content focuses on the procedural and legal compliance aspects of the transaction rather than presenting financial statements or results. It is not a full financial report, earnings release, or audit report, nor is it a simple announcement or certification. The document is a formal board/management statement about the restructuring process and legal compliance, fitting the category of Board/Management Information (MANG). The document length is 3662 characters, which is substantial but not a full annual or interim report. Therefore, the best classification is MANG with high confidence.
2022-05-25 Chinese
国泰君安证券股份有限公司关于本次交易符合《关于加强证券公司在投资银行类业务中聘请第三方等廉洁从业风险防控的意见》相关规定的核查意见
Regulatory Filings Classification · 95% confidence The document is a formal opinion from Guotai Junan Securities Co., Ltd. regarding compliance with regulatory requirements related to the engagement of third parties in an investment banking transaction. It references the China Securities Regulatory Commission's guidelines and confirms that no improper third-party engagements occurred in the transaction involving Xinjiang Xuefeng Technology (Group) Co., Ltd. The document is a compliance and regulatory check related to a specific transaction, not a full financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data but rather a regulatory compliance opinion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories. The document length is short (1292 characters), and it is not an announcement of a report but a standalone compliance opinion.
2022-05-25 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.